Blood is a specialized connective tissue that plays a central role in transport, regulation, and protection within the body. It circulates through a closed system of blood vessels and is essential for maintaining homeostasis.
Plasma is the straw-colored fluid that remains after removal of blood cells. It is ~92% water and serves as the transport medium for nutrients, hormones, and waste.
Component | Percentage/Details | Function |
---|---|---|
Water (92%) | Solvent medium | Maintains volume and transports substances |
Plasma proteins (7%) | Albumin, globulins, fibrinogen | Maintain osmotic pressure, immunity, clotting |
Electrolytes | Na⁺, K⁺, Ca²⁺, Cl⁻, HCO₃⁻ | Acid-base balance, nerve/muscle function |
Nutrients | Glucose, amino acids, lipids | Energy supply and tissue repair |
Gases | O₂, CO₂, N₂ | Cellular respiration and waste elimination |
Waste products | Urea, creatinine, bilirubin | Excreted by kidneys or liver |
Hormones and enzymes | Various | Regulation of physiological processes |
These are the cellular components suspended in plasma, produced primarily in the red bone marrow.
Type | % of WBCs | Function |
---|---|---|
Neutrophils | 60–70% | Phagocytosis of bacteria |
Eosinophils | 2–4% | Combat parasites, allergic response |
Basophils | <1% | Release histamine in inflammation |
Type | % of WBCs | Function |
---|---|---|
Lymphocytes | 20–25% | B and T cells – immunity |
Monocytes | 3–8% | Phagocytosis, become macrophages |
Component | % of Total Volume | Key Function |
---|---|---|
Plasma | ~55% | Transport, pH balance, immunity, clotting |
RBCs | ~44% | Oxygen and CO₂ transport |
WBCs | <1% | Defense against pathogens |
Platelets | <1% | Hemostasis (clot formation) |
Condition | Blood Composition Change |
---|---|
Anemia | ↓ RBC count/hemoglobin |
Leukocytosis | ↑ WBC count (infection, leukemia) |
Thrombocytopenia | ↓ Platelets (bleeding risk) |
Dehydration | ↑ Hematocrit due to plasma volume loss |
Hyperproteinemia | ↑ Plasma proteins (e.g., in multiple myeloma) |
Hypoproteinemia | ↓ Albumin (malnutrition, liver disease) |
Blood is a complex, multifunctional fluid made of plasma and formed elements. Its composition reflects and affects nearly every aspect of human physiology—transport, immunity, clotting, and pH balance—making it central to both health assessment and disease diagnosis.
Blood is a life-sustaining fluid tissue that circulates through the cardiovascular system, delivering substances essential for cellular functions and removing waste products. Its dynamic composition supports multiple physiological systems—including respiratory, immune, excretory, regulatory, and endocrine functions.
Blood performs three main categories of functions:
Blood serves as the primary transport medium in the body.
Blood plays a key role in homeostasis by regulating internal environmental conditions.
The blood helps defend the body against pathogens, injury, and bleeding.
Category | Specific Function |
---|---|
Transport | O₂, CO₂, nutrients, hormones, waste |
Regulation | pH, temperature, osmotic balance, blood volume |
Protection | Immune defense, clotting, wound healing, detox |
Condition | Impaired Function |
---|---|
Anemia | ↓ Oxygen-carrying capacity |
Leukopenia/Leukocytosis | Immune suppression / hyperactivity |
Dehydration | ↓ Plasma volume → hypotension |
Liver failure | ↓ Clotting proteins → bleeding risk |
Sepsis | Disrupted regulation → shock, clotting imbalance |
Blood is not just a transport medium—it is a multifunctional connective tissue that plays crucial roles in sustaining life, maintaining balance, and defending against harm. For nurses and clinicians, recognizing alterations in these functions is vital for early diagnosis, treatment, and care planning in both acute and chronic illnesses.
Blood is a specialized connective tissue with unique physical properties that allow it to circulate efficiently throughout the vascular system. Its color, volume, viscosity, temperature, and pH contribute to its ability to perform vital transport, regulatory, and protective functions.
🧠 Color changes are clinically significant in assessing hypoxia, cyanosis, or carbon monoxide poisoning.
🩺 Blood volume is crucial in managing fluid therapy, blood transfusions, and shock.
🔍 Clinical Relevance:
🧠 Useful in thermoregulation and fever response.
⚠️ Deviations:
(Not typically used in diagnosis but relevant to understanding waste accumulation in renal failure or sepsis.)
Characteristic | Normal Value/Description | Clinical Significance |
---|---|---|
Color | Bright red (oxygenated), dark red (deoxygenated) | Reflects oxygen saturation |
Volume | 4–6 L (avg adult) | Guides fluid replacement, transfusion |
Viscosity | 4–5× thicker than water | Affects blood flow and cardiac workload |
Temperature | ~38°C (100.4°F) | Thermoregulation |
pH | 7.35–7.45 (slightly alkaline) | Buffer function, metabolic and respiratory balance |
Specific gravity | 1.050–1.060 | Relates to cell/plasma content |
Osmotic pressure | ~25 mmHg (colloid pressure) | Maintains fluid balance in capillaries |
The physical properties of blood are essential for its role in circulation, oxygen delivery, waste removal, and regulation of body conditions. These characteristics form the foundation for interpreting clinical symptoms, performing diagnostic tests, and providing targeted care in various health conditions.
Hematopoiesis (or hemopoiesis) is the physiological process by which the body produces blood cells. It occurs continuously throughout life to replenish cells that are used, aged, or lost due to bleeding or disease.
All blood cells originate from pluripotent hematopoietic stem cells in the red bone marrow through a tightly regulated process involving growth factors, cytokines, and cell differentiation.
Life Stage | Primary Sites |
---|---|
Embryonic (first 2 months) | Yolk sac |
Fetal (2–7 months) | Liver and spleen |
Late fetal and after birth | Red bone marrow (sternum, ribs, pelvis, vertebrae, skull, proximal long bones) |
In adults, flat bones are the major hematopoietic sites.
All blood cells arise from hematopoietic stem cells (HSCs), which differentiate into:
Lymphocytes are key players in adaptive immunity.
Cell Type | Origin | Key Hormone | Primary Function |
---|---|---|---|
RBCs | Myeloid stem cell | Erythropoietin | O₂ and CO₂ transport |
Platelets | Myeloid stem cell | Thrombopoietin | Blood clotting |
Neutrophils | Myeloid stem cell | G-CSF | Phagocytosis of bacteria |
Eosinophils | Myeloid stem cell | GM-CSF | Allergy & parasite defense |
Basophils | Myeloid stem cell | GM-CSF | Release histamine in inflammation |
Monocytes | Myeloid stem cell | M-CSF | Become macrophages; phagocytosis |
B Lymphocytes | Lymphoid stem cell | IL-7 | Antibody production |
T Lymphocytes | Lymphoid stem cell | IL-2, IL-7 | Cell-mediated immunity |
NK Cells | Lymphoid stem cell | IL-15 | Non-specific immune response |
Condition | Effect on Hematopoiesis |
---|---|
Anemia | Decreased erythropoiesis or nutrient deficiency |
Leukemia | Uncontrolled proliferation of abnormal WBCs |
Aplastic anemia | Bone marrow failure (↓ all cell lines) |
Polycythemia vera | Excess RBC production → ↑ viscosity, clot risk |
Chemotherapy | Suppresses bone marrow → pancytopenia |
Bone marrow transplant | Replaces defective hematopoietic stem cells |
Blood cell formation (hematopoiesis) is a complex, finely regulated process vital for:
Understanding its mechanisms enables healthcare professionals to interpret CBC results, manage blood disorders, and support patients undergoing therapies that affect bone marrow function.
Erythropoiesis is the process of red blood cell (erythrocyte) formation. It occurs in the red bone marrow and is stimulated by hypoxia (low oxygen levels in tissues), which triggers the release of erythropoietin, a hormone produced mainly by the kidneys.
Erythropoiesis involves the transformation of a pluripotent stem cell into a mature RBC over ~5–7 days:
🧪 Reticulocyte count (~1–2%) reflects bone marrow activity.
Factor | Role |
---|---|
Erythropoietin | Stimulates proliferation & differentiation |
Iron | Required for hemoglobin synthesis |
Vitamin B₁₂ & Folate | Needed for DNA synthesis in erythroblasts |
Amino acids & Copper | Support globin and enzyme production |
Function | Explanation |
---|---|
Oxygen transport | Hemoglobin binds O₂ in lungs and releases it in tissues |
Carbon dioxide transport | Carries CO₂ from tissues to lungs (as carbaminohemoglobin or HCO₃⁻) |
Buffering pH | Hemoglobin acts as a buffer by binding H⁺ and maintaining blood pH |
Maintaining blood viscosity | Contributes to blood flow dynamics and pressure |
Condition | Effect on Erythropoiesis / RBCs |
---|---|
Anemia | ↓ RBCs or hemoglobin → fatigue, pallor |
Polycythemia vera | Excess RBCs → ↑ blood viscosity, clot risk |
Iron-deficiency anemia | Poor hemoglobin synthesis |
Vitamin B12/Folate deficiency | Impaired DNA synthesis → megaloblastic anemia |
Chronic kidney disease | ↓ erythropoietin production → anemia |
Hemolytic anemia | Premature RBC destruction |
Stage | Key Feature | Time |
---|---|---|
Proerythroblast | Large, nucleated cell | Day 1 |
Erythroblast | Hemoglobin starts to form | Days 2–3 |
Normoblast | Nucleus condenses and is expelled | Day 4 |
Reticulocyte | Enters blood, still has RNA | Day 5–6 |
Mature RBC | Fully functional, anucleate | Day 7 |
Lifespan | Circulates, performs functions | ~120 days |
Erythropoiesis is the vital process of red blood cell production, essential for oxygen delivery and acid-base regulation. The mature RBC, though simple in structure, plays a critical role in sustaining life and is a key indicator of many systemic health conditions.
White Blood Cells (WBCs), also known as leukocytes, are the body’s primary defense cells, protecting against infections, foreign bodies, allergens, and abnormal cells (e.g., cancerous cells). Unlike RBCs, WBCs are nucleated, colorless, and capable of movement through tissue spaces.
WBCs are classified into two major groups based on the presence or absence of cytoplasmic granules:
Type | Abundance in Blood | Key Functions |
---|---|---|
Neutrophils | 60–70% | First responders; phagocytose bacteria, fungi |
Eosinophils | 2–4% | Attack parasites; modulate allergic response |
Basophils | <1% | Release histamine in allergies/inflammation |
Type | Abundance in Blood | Key Functions |
---|---|---|
Lymphocytes | 20–25% | Adaptive immunity (B and T cells) |
Monocytes | 3–8% | Differentiate into macrophages; phagocytosis |
Type | Appearance | Key Role |
---|---|---|
Neutrophils | Multi-lobed nucleus, pale granules | Phagocytosis of bacteria |
Eosinophils | Bi-lobed nucleus, red granules | Parasite killing, allergy moderation |
Basophils | Dark purple granules | Histamine release, allergic reactions |
Lymphocytes | Large round nucleus, thin cytoplasm | Adaptive immunity (B, T, NK cells) |
Monocytes | Kidney-shaped nucleus | Phagocytosis, macrophage precursor |
Condition | WBC Change |
---|---|
Bacterial infection | ↑ Neutrophils (Neutrophilia) |
Viral infection | ↑ Lymphocytes (Lymphocytosis) |
Parasitic infection | ↑ Eosinophils (Eosinophilia) |
Allergic reaction | ↑ Basophils and Eosinophils |
Chronic inflammation | ↑ Monocytes (Monocytosis) |
Leukopenia | ↓ Total WBCs (e.g., chemotherapy) |
Leukemia | Uncontrolled WBC production (immature) |
White blood cells are key players in immune surveillance, defense, and tissue repair. Each type has a specialized function, and their levels are crucial indicators in infection, inflammation, immune disorders, and hematologic diseases.
Understanding their types and roles equips healthcare professionals to interpret CBCs, manage immunocompromised patients, and respond to infectious or allergic emergencies.
Platelets, or thrombocytes, are cell fragments that play a crucial role in blood clotting (hemostasis) and wound healing. They are not true cells but are derived from megakaryocytes in the bone marrow.
Feature | Details |
---|---|
Shape | Small, disc-shaped fragments |
Size | ~2–3 µm in diameter |
Count (normal) | 150,000–400,000/µL of blood |
Lifespan | 7–10 days in circulation |
Removal | Cleared by spleen and liver macrophages |
Platelets lack a nucleus, but contain granules with important substances for clotting and tissue repair.
Thrombopoiesis is the process of platelet formation and maturation in the red bone marrow.
Condition | Effect |
---|---|
Thrombocytopenia | Platelet count <150,000/µL → bleeding risk |
Thrombocytosis | Platelet count >400,000/µL → clot risk |
Aspirin/NSAIDs use | Inhibits platelet aggregation |
Leukemia or chemotherapy | Suppressed marrow → low platelet production |
ITP (Immune Thrombocytopenia) | Autoimmune destruction of platelets |
🧪 Platelet function tests (e.g., bleeding time, platelet aggregation) help assess clotting ability.
Feature | Detail |
---|---|
Origin | Megakaryocytes in bone marrow |
Hormone Stimulus | Thrombopoietin (TPO) |
Normal Count | 150,000–400,000/μL |
Lifespan | 7–10 days |
Function | Hemostasis, clot formation, healing |
Clinical Disorders | Thrombocytopenia, thrombocytosis |
Platelets are indispensable for hemostasis, enabling the body to quickly respond to vascular injury and initiate clotting. They also support wound healing and help maintain vascular integrity. Their production (thrombopoiesis) is tightly regulated, and dysfunction can lead to life-threatening bleeding or thrombosis.
Blood clotting (also known as coagulation) is a complex physiological process that prevents excessive blood loss following vascular injury. It involves platelets, clotting factors, vascular endothelium, and fibrin formation.
The clotting process occurs in three phases:
This occurs through two pathways, both leading to activation of Factor X:
✅ Both pathways converge to activate Factor X, beginning the common pathway.
Pathway | Trigger | Key Factors Involved |
---|---|---|
Intrinsic | Contact with damaged endothelium | XII, XI, IX, VIII, X, V, II, I |
Extrinsic | Tissue trauma (TF release) | VII, X, V, II, I |
Common Pathway | Activation of Factor X | X → Prothrombin → Thrombin → Fibrinogen → Fibrin |
Time taken for blood to form a clot in vitro after being exposed to air.
🩺 Prolonged clotting time seen in hemophilia, severe liver disease, anticoagulant therapy
Time taken for bleeding to stop from a small skin puncture.
🩺 Prolonged bleeding time in thrombocytopenia, von Willebrand disease, aspirin use
Time taken for plasma to clot after adding calcium, phospholipid, and an activator.
🩺 Prolonged PTT in:
Test | Measures | Normal Range | Used For |
---|---|---|---|
Bleeding Time | Platelet function & capillary integrity | 1–6 minutes | von Willebrand disease, aspirin use |
Clotting Time | Coagulation time in whole blood | 5–11 minutes | Hemophilia, liver disease |
PTT / aPTT | Intrinsic & common pathway factors | 25–40 seconds | Monitor heparin, screen hemophilia |
After clot formation:
Condition | Coagulation Profile |
---|---|
Hemophilia A/B | ↑ PTT, normal BT & PT |
Von Willebrand disease | ↑ BT, possibly ↑ PTT |
Liver disease | ↑ CT, PT, PTT due to impaired clotting factor synthesis |
Heparin therapy | ↑ aPTT |
Warfarin therapy | ↑ PT, normal or mildly ↑ aPTT |
The clotting mechanism is a finely regulated cascade involving platelets, clotting factors, and fibrin, ensuring that bleeding stops while maintaining normal circulation. Laboratory tests like BT, CT, and PTT help in diagnosing coagulation disorders, monitoring therapies, and guiding patient management.
Vasoconstriction, also called vascular spasm, is the first immediate response in the process of hemostasis—the body’s way of stopping blood loss after injury to a blood vessel. It is crucial for minimizing blood flow to the damaged area and giving time for platelet plug formation and coagulation to occur.
When a blood vessel is injured, the smooth muscle in the vessel wall contracts. This constriction:
Aspect | Details |
---|---|
What is it? | Constriction of injured blood vessel |
When does it occur? | Immediately after vascular injury |
Why is it important? | Reduces blood loss and prepares for next steps |
Mediators involved | Serotonin, Thromboxane A₂, Endothelin |
Clinical importance | Aids in surgical bleeding control, trauma care |
Platelet plug formation is the second critical step in the hemostatic process, following vascular spasm (vasoconstriction). It constitutes primary hemostasis, where platelets adhere, activate, and aggregate at the site of vascular injury to form a temporary plug that seals small vessel injuries.
Once adhered, platelets undergo several changes:
Substance | Source | Function |
---|---|---|
von Willebrand factor (vWF) | Damaged endothelium, platelets | Platelet adhesion to collagen |
ADP | Platelet granules | Platelet activation and aggregation |
Thromboxane A₂ | Platelets | Vasoconstriction and platelet recruitment |
Serotonin | Platelets | Promotes vasoconstriction |
Fibrinogen | Plasma | Forms bridges between platelets |
Platelet Plug (Primary Hemostasis) | Fibrin Clot (Secondary Hemostasis) |
---|---|
Formed by platelets only | Stabilized by fibrin |
Quick, temporary | Delayed, long-lasting |
Effective in small vessel injury | Essential in large vessel or deep injury |
Condition | Effect on Platelet Plug Formation |
---|---|
Thrombocytopenia | ↓ Platelet count → impaired plug formation |
Aspirin use | Inhibits TXA₂ → ↓ platelet aggregation |
von Willebrand disease | Defective vWF → ↓ adhesion |
Glanzmann’s thrombasthenia | Defective GPIIb/IIIa → ↓ aggregation |
Platelet plug formation is a fast, highly regulated process that prevents excessive blood loss after vascular injury. It relies on:
This step is essential for initiating coagulation, especially in microvascular injuries, and any disruption can lead to bleeding disorders.
Coagulation factors (also known as clotting factors) are a group of proteins—mostly enzymes—that work in a coordinated cascade to form a stable blood clot in response to vascular injury. They are primarily produced by the liver, with some requiring vitamin K for synthesis.
These factors are involved in the coagulation cascade, which consists of intrinsic, extrinsic, and common pathways.
Factor | Name | Function |
---|---|---|
I | Fibrinogen | Converted to fibrin by thrombin |
II | Prothrombin | Converted to thrombin, a key enzyme in clotting |
III | Tissue Factor (Thromboplastin) | Triggers extrinsic pathway |
IV | Calcium (Ca²⁺) | Essential cofactor in many clotting reactions |
V | Labile Factor | Cofactor for prothrombinase complex |
VII | Stable Factor | Initiates extrinsic pathway with tissue factor |
VIII | Anti-hemophilic Factor A | Cofactor in intrinsic pathway (deficient in Hemophilia A) |
IX | Anti-hemophilic Factor B | Also called Christmas factor (deficient in Hemophilia B) |
X | Stuart-Prower Factor | Point of convergence for intrinsic and extrinsic pathways |
XI | Plasma Thromboplastin Antecedent | Involved in intrinsic pathway |
XII | Hageman Factor | Activates Factor XI and fibrinolysis |
XIII | Fibrin-stabilizing Factor | Cross-links fibrin to stabilize the clot |
🧬 Factors I, II, V, VII, VIII, IX, X, XI, XII, and XIII are proteins; Factor IV is calcium.
Activated by damage inside the vessel
Involves: XII, XI, IX, VIII
Activated by external trauma
Involves: III (Tissue Factor), VII
Point of convergence
Involves: X, V, II (prothrombin), I (fibrinogen), XIII
Test | Measures | Clinical Use |
---|---|---|
PT (Prothrombin Time) | Factors I, II, V, VII, X (Extrinsic + Common) | Monitors warfarin therapy |
aPTT (Activated Partial Thromboplastin Time) | Factors I, II, V, VIII, IX, X, XI, XII | Monitors heparin therapy |
TT (Thrombin Time) | Conversion of fibrinogen to fibrin | Screens for dysfibrinogenemia |
“Foolish People Try Climbing Long Slopes After Christmas Some People Have Fallen.”
Word | Factor |
---|---|
Foolish | Factor I (Fibrinogen) |
People | Factor II (Prothrombin) |
Try | Factor III (Tissue Factor) |
Climbing | Factor IV (Calcium) |
Long | Factor V (Labile Factor) |
Slopes | Factor VII (Stable Factor) |
After | Factor VIII (Anti-hemophilic A) |
Christmas | Factor IX (Anti-hemophilic B) |
Some | Factor X (Stuart-Prower) |
People | Factor XI (PTA) |
Have | Factor XII (Hageman) |
Fallen | Factor XIII (Fibrin-stabilizing) |
Coagulation factors are vital for initiating, amplifying, and stabilizing blood clot formation. Any deficiency or dysfunction in these factors can lead to bleeding disorders like hemophilia, vitamin K deficiency bleeding, or DIC.
The coagulation cascade is the series of enzymatic reactions that leads to the formation of a fibrin clot. It is classically divided into:
Activated by endothelial injury or exposure of blood to subendothelial collagen, without the involvement of tissue factor.
Triggered by external trauma that leads to the release of Tissue Factor (TF), also known as Factor III, from damaged tissues.
Both intrinsic and extrinsic pathways converge here:
Feature | Intrinsic Pathway | Extrinsic Pathway |
---|---|---|
Trigger | Endothelial damage, exposed collagen | Tissue injury releasing TF |
Initiating Factor | Factor XII | Factor III (Tissue Factor) + Factor VII |
Speed | Slower (minutes) | Faster (seconds) |
Lab Test | aPTT (Activated Partial Thromboplastin Time) | PT (Prothrombin Time), INR |
Clotting Factors | XII, XI, IX, VIII | III, VII |
Used to Monitor | Heparin therapy | Warfarin therapy |
Condition | Pathway Affected | Lab Findings |
---|---|---|
Hemophilia A (Factor VIII deficiency) | Intrinsic | ↑ aPTT |
Hemophilia B (Factor IX deficiency) | Intrinsic | ↑ aPTT |
Vitamin K deficiency | Both (affects II, VII, IX, X) | ↑ PT and aPTT |
Liver disease | All pathways | ↑ PT and aPTT |
Disseminated Intravascular Coagulation (DIC) | All pathways | ↑ PT, ↑ aPTT, ↓ platelets, ↓ fibrinogen |
Both the intrinsic and extrinsic pathways are critical to initiating the coagulation cascade. While they differ in their triggers and speed, they converge on the common pathway to produce thrombin, which is essential for fibrin clot formation.
Understanding these pathways is vital for interpreting coagulation tests, diagnosing bleeding disorders, and managing patients on anticoagulants.
Blood grouping is the classification of blood based on the presence or absence of specific antigens on the surface of red blood cells (RBCs) and the corresponding antibodies in the plasma. It is crucial for safe blood transfusions, organ transplantation, and in prenatal care.
The two most important blood group systems are:
The ABO system is based on the presence or absence of two antigens—A and B—on the surface of RBCs, and the presence of anti-A and/or anti-B antibodies in the plasma.
Blood Group | RBC Antigens | Plasma Antibodies | Can Donate To | Can Receive From |
---|---|---|---|---|
A | A antigen | Anti-B | A, AB | A, O |
B | B antigen | Anti-A | B, AB | B, O |
AB | A and B antigens | None | AB | A, B, AB, O (Universal recipient) |
O | None | Anti-A and Anti-B | A, B, AB, O (Universal donor) | O |
Blood Type | Antigens on RBCs | Antibodies in Plasma | % Population (approx.) |
---|---|---|---|
A+ | A, Rh(D) | Anti-B | ~34% |
A– | A | Anti-B, possibly Anti-D | ~6% |
B+ | B, Rh(D) | Anti-A | ~9% |
B– | B | Anti-A, possibly Anti-D | ~2% |
AB+ | A, B, Rh(D) | None | ~4% |
AB– | A, B | Possibly Anti-D | ~1% |
O+ | None, Rh(D) | Anti-A, Anti-B | ~37% |
O– | None | Anti-A, Anti-B, possibly Anti-D | ~7% |
🔖 O– is the universal donor for RBCs, AB+ is the universal recipient.
Before a transfusion:
Application | Purpose |
---|---|
Blood transfusion | Avoids incompatible transfusions |
Organ transplantation | Minimizes rejection risk |
Pregnancy care | Manages Rh incompatibility |
Forensic science and paternity testing | Identifies relationships or individuals |
Blood bank storage and management | Ensures inventory of all blood types |
Blood groups are determined by genetically inherited antigens on RBCs. Understanding the ABO and Rh systems is essential for safe transfusion, prenatal care, and medical emergencies. Mismatched blood transfusions can be fatal, highlighting the importance of proper blood typing and cross-matching.
The process is known as blood grouping or forward typing and involves testing a person’s RBC antigens with known antisera (antibodies). The most common and rapid method is the slide method or tube method.
Agglutination with | Blood Group |
---|---|
Anti-A only | A |
Anti-B only | B |
Both Anti-A and Anti-B | AB |
Neither | O |
Agglutination with Anti-D | Rh Type |
---|---|
Yes | Rh positive |
No | Rh negative |
🔖 Example: Agglutination with Anti-B and Anti-D → B positive
Blood group and Rh typing is a simple, rapid, yet critical procedure in:
It ensures donor-recipient compatibility and prevents life-threatening transfusion reactions.
The reticuloendothelial system (RES) is a network of phagocytic cells located in various tissues, responsible for recognizing, engulfing, and destroying foreign substances, dead cells, and pathogens. It is now more accurately referred to as the mononuclear phagocyte system (MPS) due to its cellular components.
The system is made up of monocytes in the blood and macrophages in tissues. These include:
Cell Type | Location | Special Name |
---|---|---|
Monocytes | Blood circulation | — |
Macrophages | General tissue | Tissue macrophages |
Kupffer cells | Liver | Specialized hepatic macrophages |
Alveolar macrophages | Lungs | Dust cells |
Microglia | Central nervous system | Brain macrophages |
Langerhans cells | Skin | Dendritic antigen-presenting cells |
Splenic macrophages | Spleen (red pulp) | — |
Lymph node macrophages | Lymphatic tissue | — |
Osteoclasts | Bone | Bone-resorbing macrophages |
Function | Description |
---|---|
Phagocytosis | Engulfment and digestion of pathogens and debris |
Antigen presentation | Activation of T-cells for adaptive immunity |
RBC breakdown | Splenic/liver macrophages recycle iron and remove aged RBCs |
Cytokine secretion | Modulates inflammation and immune response |
Iron storage | Stores iron for hemoglobin production |
Immune surveillance | Monitors tissues for antigens and abnormal cells |
Removal of immune complexes | Clears harmful circulating antigen–antibody complexes |
Tissue repair | Releases factors that assist in wound healing and tissue regeneration |
Condition | Impact on RES Function |
---|---|
Sepsis | Hyperactivation of macrophages → systemic inflammation |
HIV/AIDS | Impaired macrophage–T cell interaction |
Splenectomy | Loss of key RES organ → risk of infection |
Gaucher’s disease | Defect in macrophage lysosomal enzyme → accumulation |
Iron overload (hemochromatosis) | Overwhelms macrophage storage capacity |
Autoimmune diseases | Defective clearance of immune complexes |
The reticuloendothelial system is essential for:
Its proper function is critical for maintaining immune homeostasis, and its dysfunction can lead to infection, autoimmunity, or impaired healing.
Immunity refers to the body’s ability to recognize, resist, and eliminate pathogens, harmful substances, and abnormal cells. It is a vital defense mechanism that maintains homeostasis and protects the body from infections, cancer, and foreign substances.
Immunity is carried out through a complex network of organs, cells, and molecules organized into innate and adaptive systems.
Type | Description | Onset | Specificity | Memory |
---|---|---|---|---|
Innate | Present at birth, non-specific | Immediate | Non-specific | No |
Adaptive | Acquired after exposure to specific antigens | Delayed | Highly specific | Yes |
Condition | Related Immune Dysfunction |
---|---|
Immunodeficiency (e.g., HIV) | ↓ Defense against infections |
Autoimmune diseases | Failure to recognize self |
Allergies | Exaggerated response to harmless antigens |
Cancer | Failure in immune surveillance |
Organ rejection | Excessive cell-mediated immunity |
Vaccination | Based on immunological memory |
Function | Key Cells Involved | Purpose |
---|---|---|
Self/non-self recognition | T cells, APCs | Maintain tolerance |
Pathogen elimination | Neutrophils, macrophages, T cells | Prevent infection |
Antibody production | B cells, plasma cells | Neutralize and eliminate antigens |
Inflammation | Mast cells, cytokines, complement | Recruit and activate immune cells |
Memory generation | Memory B & T cells | Faster response to repeated infections |
Tumor surveillance | NK cells, cytotoxic T cells | Destroy mutated cells |
Regulation of response | Regulatory T cells | Prevent autoimmunity and overreaction |
The immune system performs critical protective, regulatory, and restorative functions, defending the body against infections and abnormal cells, while maintaining tolerance and homeostasis. Dysfunction of these functions leads to infection, cancer, autoimmune diseases, or hypersensitivity reactions.
Blood is a specialized connective tissue vital to human life. It performs key roles in transport, regulation, and protection. Understanding its composition and function is essential for nurses to assess, monitor, and manage various clinical conditions.
Blood is made up of two main components:
Component | Function |
---|---|
Water (~92%) | Solvent, temperature regulation, transport medium |
Plasma proteins | Albumin (osmotic pressure), Globulins (immunity), Fibrinogen (clotting) |
Electrolytes | Na⁺, K⁺, Ca²⁺, HCO₃⁻ – essential for nerve and muscle function |
Nutrients | Glucose, amino acids, lipids – cellular metabolism |
Hormones & Enzymes | Regulation of body functions |
Waste products | Urea, creatinine – excreted by kidneys |
Cell Type | Normal Range | Function |
---|---|---|
RBCs (Erythrocytes) | 4.5–6 million/μL | Transport O₂ and CO₂ via hemoglobin |
WBCs (Leukocytes) | 4,000–11,000/μL | Defense against infection |
Platelets (Thrombocytes) | 150,000–400,000/μL | Blood clotting and vessel repair |
Nursing Area | Relevance of Blood Composition and Function |
---|---|
Vital signs monitoring | Detect changes in perfusion and oxygenation (e.g., anemia, hypoxia) |
IV fluid and electrolyte therapy | Requires knowledge of plasma electrolytes and osmotic balance |
Wound healing and infection control | WBC count and immune response guide antibiotic therapy |
Transfusion therapy | Requires understanding of blood components, compatibility, reactions |
Drug administration | Plasma protein levels affect drug binding and bioavailability |
Hemostasis monitoring | Platelet counts and clotting factors guide bleeding control |
Nutritional assessment | RBCs reflect iron, B12, and folate status |
Pre and post-operative care | Monitoring for anemia, infection risk, and clotting abnormalities |
A comprehensive understanding of the composition and functions of blood is essential for nurses to:
Blood plays a central role in physiological function, and understanding its composition, functions, and disorders is fundamental to nursing care. Nurses encounter and manage blood-related scenarios across a wide range of settings—from routine monitoring to emergency interventions.
Nurses frequently monitor and interpret blood investigations:
Test | Nursing Application |
---|---|
Hemoglobin (Hb) | Detects anemia or bleeding |
WBC Count | Indicates infection or immune suppression |
Platelet Count | Assesses bleeding risk, thrombocytopenia |
Coagulation Profile (PT, aPTT, INR) | Monitors clotting status, esp. during anticoagulant therapy |
Blood Grouping & Cross-Matching | Essential before transfusions |
Nurses play a vital role in safe transfusion practices:
Nurses manage blood-related emergencies like:
Domain | Application |
---|---|
Assessment | Vital signs, pallor, perfusion, bleeding signs |
Diagnostics | CBC, ESR, coagulation tests, blood cultures |
Interventions | Transfusion, oxygen therapy, IV fluids |
Monitoring | Post-surgical bleeding, transfusion reactions |
Emergency Care | Hemorrhage, sepsis, shock |
Health Promotion | Blood donation, nutrition, vaccination |
Blood is not only the medium of life but also a clinical indicator, therapeutic target, and intervention point in nursing. A nurse’s ability to assess, interpret, and respond to blood-related changes directly affects patient outcomes in both acute and chronic care settings.